Ingrédients et solutions pour l’industrie alimentaire

Microbiome

Micro-organismes et principes actifs pour la santé humaine

Agro-vet

Ferments lactiques pour le secteur agro-vétérinaire

Notre engagement en faveur du développement durable : bilan d’une trajectoire évolutive

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir. Ces dernières années, nous avons mis en œuvre des projets significatifs, notamment dans le domaine de l’économie circulaire, transformant notre cycle de production. Grâce à ces initiatives, nous avons réduit de 70 % la production de déchets, en redirigeant plus de 12 000 tonnes de sous-produits par an vers de nouveaux cycles de production, prolongeant ainsi la durée de vie des matériaux dans les chaînes de valeur.

Sur le plan social, nous nous sommes concentrés sur la croissance et la stabilité de nos collaborateurs : plus de 97 % de nos contrats sont à durée indéterminée et près de 95 % de notre personnel a participé à des activités de formation. Cette approche nous a permis de faire preuve de résilience face à des périodes complexes comme la pandémie.

Pour Sacco System, la durabilité est un pilier stratégique qui guide la recherche et l’innovation, visant à relever des défis mondiaux tels que la réduction du gaspillage alimentaire et la promotion de chaînes d’approvisionnement agroalimentaires durables.

À partir de 2026, nous respecterons la directive européenne sur la publication d’informations en matière de durabilité (CSRD), une étape cruciale pour consolider notre démarche. Nous travaillons déjà sur un reporting intégré, impliquant toutes les entreprises du groupe et actualisant les thématiques matérielles selon le principe de double matérialité, afin d’assurer un modèle commercial aligné sur les attentes des parties prenantes et les défis environnementaux et sociaux.

Sacco System continuera à contribuer au développement durable, en s’adaptant à un contexte en constante évolution et en garantissant un modèle résilient grâce au dialogue et à l’engagement avec tous nos partenaires.

Ultime news

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 janvier 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes’ mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the ribbon has been cut on the new Sacco System development site in Brisbane – Australia. Sacco System is a company with strong values, born over 150 years ago and still owned by the Verga Family, starting with the rennet production, nowadays is recognized worldwide as a biotech excellence in the production if enzyme, cultures, probiotics, postbiotics and LPB’s.

« Our Brisbane laboratories are designed to deliver early development for our fermentations. We aim to create industrial processes that are robust, reliable and compliant to regulation for a broad variety of microbes. Starting with our in-silico work we can bring all steps of fermentations to a volume of 30L to deliver the information necessary for our larger scale facilities to work effectively ”, said Max Rossetto, Microbial Therapeutics Global Business Development Director.

« Being in Australia opening our development site for Next-gen microorganisms and live biotherapeutics is sensational and absolutely and totally inspirational per se. And working hard to make it became an excellence for Sacco System Group and for the Australian State is what we should be inspired to do in the next years! ” said Viola Verga during her speech during the Grand Opening.

Australia was chosen as the site of our process development related to Next-gen microorganisms and live biotherapeutics for a number of reasons. It is easy set up a business in Australia, a modern, high quality business location with stable government, transparent regulations and which has deep and broad connections with Italy as mentioned by the Consul. This together with the presence of a cluster of microbiome related businesses and an impressive academic sector in Southern Queensland made Brisbane a natural choice for the first Sacco System site in the Asia Pacific region.

Latest News

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 janvier 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes’ mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration

Sacco System est aujourd’hui une réalité internationale, qui a réussi à maintenir un esprit de famille où les personnes et les relations humaines sont au centre.

Collaborateurs, fournisseurs et clients font partie d’une grande famille où le respect et l’attention comptent avant tout, comme en témoigne la mission: “Supporting food culture and life”, c’est-à-dire l’attention portée au soutien et à l’amélioration du bien-être des personnes.
La haute qualité des produits, le processus d’innovation continu et constant, la capacité de travailler aux côtés de nos clients, le partage des connaissances, la formation de nos employés et un regard attentif sur l’environnement qui nous entoure, sont les piliers de l’organisation Sacco System.


Sacco System compte plus de 460 collaborateurs et un chiffre d’affaires de plus de 150 millions d’euros (2022). Les usines de production sont situées à Cadorago (CO), Zelo Buon Persico (LO), Skurup (Suède) et Franksville (Wisconsin); il existe des succursales à Singapour, en France, au Japon et une usine pilote dédiée aux biothérapeutiques en Australie.

CSL FRANCE, fondée en 1994, est la branche française de SACCO SYSTEM et change aujourd’hui son nom pour SACCO SYSTEM FRANCE; rien ne changera quant à la qualité du service et des produits proposés SACCO SYSTEM FRANCE, présente depuis plus de 30 ans sur le marché français, au Benelux et en Afrique francophone, propose un portefeuille complet de ferments lactiques congelés et lyophilisés, d’acidification, d’aromatisation, d’affinage, de bioprotection, de surface, gazogènes, présures et coagulants, milieux de culture, enzymes et probiotiques. Un service d’assistance technique de haut niveau et l’excellence commerciale dédiée à ses clients.

«Je suis extrêmement fier du parcours commencé en 1994 par CSL France, qui a changé de nom pour devenir Sacco System France ; aujourd’hui comme hier, toujours aux côtés des laiteries françaises, en proposant les meilleures solutions biotechnologiques et services de conseil technique.
Sacco System France est aujourd’hui une partie essentielle du groupe Sacco System; au fil du temps, la Société s’est développée grâce à l’engagement et à la compétence des Personnes qui ont travaillé et collaboré au sein de CSL France. Pour l’avenir, je vois de nombreuses nouvelles opportunités, provenant également des marchés des pays africains. En continuant à mettre l’accent sur l’excellence en matière d’assistance technique et d’orientation client, les résultats du marché ne feront que s’améliorer de jour en jour. Nos remerciements vont aux personnes qui ont contribué à cette réussite» (M. Verga – Propriété)


« Le passage de CSL France à Sacco System France est un moment très important, qui confirme notre intérêt à continuer à valoriser la tradition et le caractère unique du secteur laitier en France d’une manière de plus en plus moderne et innovante » (Adrian Gauna – Sacco System Regional Sales Director)

Ultime news

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 janvier 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes’ mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration

Vendredi dernier, le 3 mars, s’est tenue notre mini réunion technique virtuelle pour les technologues du système Sacco des Amériques.
Nous avons été rejoints par 35 technologues travaillant dans notre réseau d’assistance technique commerciale pour ce marché, avec des représentants de Fermentos del Sur (Chili), BioInsumos (Uruguay), BioInsumos (Bolivie), Chacomer (Paraguay), Provolatte (Venezuela), Raff (Mexique), Tuteur (Argentine), Sacco Brasil, Amerilac (USA), BioVItaLIve (Équateur), Sacco System (Brésil), BioVItaLIve (Équateur), Tuteur (Argentine), Sacco Brasil, Amerilac (USA), BioVItaLIve (Equateur), Distribuidora del Caribe (Amérique centrale), Abiasa (Mexique), CSL USA (USA), GLI-Linros (Pérou), et cette fois-ci avec le soutien spécial de Centro Agro Lechero, notre distributeur pour le marché colombien.
La réunion technique sur l’utilisation de notre culture Lyofast LRB dans la conservation du lait, présentant un grand nombre de cas d’application réussis en améliorant la qualité de la matière première et donc en améliorant la qualité des produits laitiers et le rendement fromager obtenu, a été un excellent espace d’enrichissement et d’échange technique pour tous les participants.

Ultime news

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 janvier 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes’ mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration

La suite complète de produits et de services adaptés au développement et à la mise à l’échelle des probiotiques, des postbiotiques et des thérapeutiques microbiennes pour les sociétés de suppléments, de biotechnologie et pharmaceutiques.

La FDA définit les produits biothérapeutiques vivants (LBP) comme des produits biologiques contenant des organismes vivants et appliqués à la prévention, au traitement ou à la guérison d’une maladie ou d’un état. L’intérêt pour les PSL en tant que solution à plusieurs troubles de santé a augmenté de façon exponentielle au cours des dernières années. En soutien total de cette vision, Sacco System lance Microbiome by Sacco System : sa gamme complète d’ingrédients actifs et de services conçus pour le développement et la mise à l’échelle de probiotiques, postbiotiques et (LBP) thérapies microbiennes pour application au supplément, biotechnologie, et industries pharmaceutiques.

Le microbiome fleurit dans l’environnement fertile de la fière tradition d’innovation et d’évolution continues de Sacco System pour répondre aux besoins changeants de nos clients mondiaux. Le lancement de la nouvelle zone de marché Microbiome apportera un soutien fondamental à nos clients dans le développement de solutions innovantes, tout en leur offrant un avantage commercial et marketing substantiel par rapport à leurs concurrents.

Sacco System Australia a été récemment fondée pour répondre aux besoins de développement de produits biothérapeutiques vivants de nos clients et nous permet de tirer parti du savoir-faire scientifique exceptionnel qui y est présent.

Sacco System lance fièrement sa nouvelle zone de marché Microbiome pour soutenir les entreprises du monde entier dans le développement, la validation des processus et la production commerciale de probiotiques, de postbiotiques, de bactéries de nouvelle génération (des souches aérobies aux souches anaérobies obligatoires) et de biothérapies vivantes (LBP).

Ultime news

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 janvier 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes’ mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration

Le président argentin Alberto Fernández a piloté, à l’usine Danone, le lancement d’un aliment produit à partir d’une souche probiotique L. rhamnosus CRL 1505™, développé par CONICET, qui améliore la santé respiratoire et gastro-intestinale.

Il s’agit d’une nouvelle gamme de yaourts qui sera distribuée dans des institutions à vocation sociale à travers le pays.

La licence de cette bactérie lactique, isolée du lait de chèvre à Tucumán, est également « exportée » – dans le cadre d’un accord entre Conicet et l’une des plus importantes sociétés productrices de probiotiques au monde, Sacco srl, qui permet sa commercialisation à être inclus dans différents aliments et produits biopharmaceutiques.

La souche L. rhamnosus CRL 1505™ est capable de stimuler le système immunitaire, d’optimiser les défenses naturelles lors de la prévention ou du traitement des infections respiratoires et intestinales causées par des virus et des bactéries, contribuant ainsi à une amélioration de la qualité de vie et de la santé.

Ressources attachées

Ultime news

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 janvier 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes’ mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration

We are glad to present our latest cultures range for plant-based fermented products, VChoice.

VChoice is a new dairy-free cultures range, composed of pure and controlled hypoallergenic cultures, free of any known allergen as well as animal-derived products.
The perfect cultures for soy, coconut, oat milk and any other plant-based fermented products, which ensure good fermentation time, texture, flavour and aroma development.

All the products of the VChoice cultures range are dairy-free.

Contact us at info@saccosystem.com to develop the best solution for your desired finished product!

Latest News

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 janvier 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes’ mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration